Boston Scientific Corp
Change company Symbol lookup
Select an option...
BSX Boston Scientific Corp
HBI HanesBrands Inc
BAC Bank of America Corp
RYB RYB Education Inc
RETA Reata Pharmaceuticals Inc
RDFN Redfin Corp
RCUS Arcus Biosciences Inc
RBWNY Koninklijke Boskalis Westminster NV
RBII Rising Biosciences Inc
RAD Rite Aid Corp
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Closing Price
$37.99
Day's Change
0.52 (1.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
38.04
Day's Low
36.70
Volume
(Light)
Volume:
10,062,952

10-day average volume:
13,275,095
10,062,952

Company Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Valuation Ratios

Price/Earnings (TTM)
286.20x
Price/Sales (TTM)
5.03x
Price/Book (MRQ)
3.85x
Price/Cash Flow (TTM)
43.56x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

May 2020
Current Month
11.2M
Previous Month
10.7M
Percent of Float
0.80%
Days to Cover
1.6086 Days

Share Information

BSX is in a share class of common stock
Float
1.4B
Shares Outstanding
1.4B
Institutions Holding Shares
1,163
92.81%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Michael F. MahoneyChmn.
  • Daniel J. BrennanCFO
  • Kevin J. BallingerExec.VP
  • Arthur C. ButcherExec.VP
  • Joseph M. FitzgeraldExec.VP

Address

Insider Trading

During the most recent quarter, 317K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.